Showing results (521-530 of 543) with videos related to
Sort By:
Pageof 55
Chemosphere|July 28, 1999
Predicting bioconcentration factors (BCFs) of polychlorinated bornane (Toxaphene) congeners in fish and comparison with bioaccumulation factors (BAFs) in biota from the aquatic environmentH J Geyer, A Kaune, K W Schramm, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2012
Haemophilia care in Europe: the ESCHQoL studyW Schramm, A Gringeri, R Ljung, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 12, 2008
Characterisation of bioactive compounds in infant formulas using immobilised recombinant estrogen receptor-alpha affinity columnsA Riu, P Balaguer, E Perdu, et al.Hamostaseologie|November 11, 2014
Risks and challenges of orthopaedic invasive interventions in haemophilia in a low-resource country. A single-center experienceM Serban, D Poenaru, J Patrascu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancerC H Köhne, P Schöffski, H Wilke, et al.Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII geneO El-Maarri, U Herbiniaux, J Graw, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and AustriaH Pollmann, D Externest, A Ganser, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2007
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study GroupA Nicholson, K Berger, R Bohn, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2014
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicityD Matino, D Lillicrap, J Astermark, et al.Hamostaseologie|November 8, 2011
Development of inhibitors in haemophilia. Ongoing epidemiological studyM Serban, D Mihailov, L Pop, et al.Pageof 55